Topical Treatment Patents (Class 514/887)
-
Patent number: 6867238Abstract: Compositions are provided for the topical treatment of cancer consisting of lotions, creams, sprays, suppositories or slow-release transdermal patches containing lipid-soluble, skin-penetrating organic selenium compounds in combination with inert carriers in therapeutically effective amounts of selenium compound. The selenium compounds are medium linear chain dialkyl diselenides and precursors such as alkyl selenols. Preferred compositions employ R—Se—Se—R compounds where R is from 6 to 8 carbon atoms, and most specifically di-n-hexyl diselenide. Commonly used carriers may be purified hydrocarbon fractions, oils, with or without added fat-soluble vitamins, water and emulsifying agents.Type: GrantFiled: June 24, 2002Date of Patent: March 15, 2005Inventor: Gerhard N. Schrauzer
-
Patent number: 6858201Abstract: Fingernail and toenail growth and repair are stimulated using an ionic metal-peptide complex. This also improves nail smoothness, strength and esthetic beauty. The peptide-ionic metal complex is comprised of an ionic metal selected from copper (II) or tin (II) and salts thereof, and the peptide component can be a acid, base, enzymatic, bacteria, or yeast hydrolyzate casein, collagen, elastin, meat products, silk protein, soybean protein, or other proteins or a chemically synthesized peptide that binds ionic metals, such as copper (II).Type: GrantFiled: February 15, 2002Date of Patent: February 22, 2005Assignee: Skin Biology, Inc.Inventor: Loren R. Pickart
-
Patent number: 6855342Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.Type: GrantFiled: December 18, 2001Date of Patent: February 15, 2005Assignee: Medicis Pharmaceutical CorporationInventors: Jonah Shacknai, Eugene H. Gans
-
Patent number: 6849277Abstract: The invention is a composition and method for prophylactic or therapeutic treating skin that is exposed to excessive amounts of moisture. The composition is an ointment or paste that includes zinc oxide, a fungicide, a bactericide, and water-absorbing macromolecular materials in a water-immiscible vehicle. The composition is adherent to the skin. The method of use includes cleaning and drying the skin, and then applying the composition to the skin. A topical anesthetic may be included as well.Type: GrantFiled: August 8, 2002Date of Patent: February 1, 2005Inventor: Juan Carlos Roig
-
Patent number: 6841161Abstract: The invention concerns a topical composition comprising an emulsion of at least one discontinuous phase in a continuous phase, the or each discontinuous phase including a eutectic mixture of first and second pharmaceutically acceptable components which are both pharmacologically active agents and the continuous phase being provided by a pharmaceutically acceptable carrier, the eutectic mixture having a melting point below 40° C. The topical composition may additionally comprise, in the eutectic mixture, a third or fourth pharmaceutically acceptable component.Type: GrantFiled: May 14, 1998Date of Patent: January 11, 2005Assignee: Galen (Chemicals) LimitedInventors: Clare Passmore, Claire Gilligan
-
Publication number: 20040223986Abstract: Use of a polyamino polymer to inhibit the light-induced peroxidation of lipids, particularly inhibition of the photo-peroxidation of lipids induced by nanopigments. The invention also relates to the use of a polyamino polymer to inhibit the light-induced peroxidation of proteins. This property of polyamino polymers finds applications in particular in the cosmetics, pharmaceutical, veterinary and agrifood fields.Type: ApplicationFiled: May 22, 1998Publication date: November 11, 2004Inventors: BOUDIAF BOUSSOUIRA, CHRISTIAN COLIN
-
Patent number: 6812215Abstract: Compositions and pharmaceutical compositions are described which comprise: a component A comprising one or more flavonol glycosides, a component B comprising one or more tetrahydrofolic acid compounds, a component C comprising one or more calcium supplements, and a component D comprising one or more magnesium supplements. Methods of using such compositions and pharmaceutical compositions to treat and/or prevent osteoporosis and/or an inflammatory joint disease are also described.Type: GrantFiled: December 2, 2002Date of Patent: November 2, 2004Assignee: Merck Patent Gesellschaft mit beschränkter HaftungInventors: Herwig Buchholz, Jerzy Meduski
-
Patent number: 6812254Abstract: A composition containing capsaicin together with other ingredients to neutralize the discomfort resulting from the application of capsaicin to the ski enabling treatment of many types of discomforts, including arthritis pain, neuropathy, post surgical scarring, hemorrhoid pain and itching, and pruritis without the discomfort normally associated with the topical application of capsaicin.Type: GrantFiled: March 24, 2000Date of Patent: November 2, 2004Assignee: Medical Merchandising Inc.Inventors: Teresa Leigh Barr, Stephen D. Holt
-
Patent number: 6797260Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.Type: GrantFiled: September 18, 2003Date of Patent: September 28, 2004Inventor: Terence Prevendar
-
Patent number: 6790849Abstract: Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the treatment, management, and/or prevention of inflammation, asthma or symptoms thereof, allergic disorders such as allergic rhinitis, and dermatitis.Type: GrantFiled: March 26, 2002Date of Patent: September 14, 2004Assignee: Sepracor Inc.Inventor: Paul D. Rubin
-
Patent number: 6756064Abstract: A therapeutic composition comprising: arnica, rosemary oil and emu oil.Type: GrantFiled: July 20, 2000Date of Patent: June 29, 2004Inventor: John William Carrol
-
Patent number: 6756060Abstract: Compositions and methods for treating wounds to significantly reduce the healing time, reduce the incidence of scar formation, improve the success of skin grafts, reduce the inflammatory response and providing anti-bacterial treatments to a patient in need thereof, that include small non-interlinked particles of bioactive glass or highly porous bioactive glass, are disclosed. Anti-bacterial solutions derived from bioactive glass, and methods of preparation and use thereof, are also disclosed. The compositions include non-interlinked particles of bioactive glass, alone or in combination with anti-bacterial agents and/or anti-inflammatory agents. The compositions can include an appropriate carrier for topical administration. Anti-bacterial properties can be imparted to implanted materials, such as prosthetic implants, sutures, stents, screws, plates, tubes, and the like, by incorporating small bioactive glass particles or porous bioactive glass into or onto the implanted materials.Type: GrantFiled: April 27, 2000Date of Patent: June 29, 2004Assignee: USBiomaterials Corp.Inventors: David C. Greenspan, Jon K. West, Sean Lee, James L. Meyers, Mason Diamond
-
Patent number: 6749869Abstract: The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The compositions of the invention are made by combining an aqueous thickened liquid composition containing the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite. The materials can be combined, blended into a smooth viscous material and can be immediately contacted with the target animals. The compositions of the invention provide rapid initial kill, consistent long term kill and chemical and rheological stability.Type: GrantFiled: September 26, 1997Date of Patent: June 15, 2004Assignee: EcolabInventors: Francis L. Richter, Cathy M. Paquette, Richard K. Staub
-
Patent number: 6737083Abstract: A reconstituted ocean mixture comprising, sea salt, and the purified product of reverse osmosis of water. A method is provided for treating a pierced area of a person's skin comprising applying to the pierced area a reconstituted ocean water mixture of sea salt and the product of reverse osmosis of water.Type: GrantFiled: August 16, 2001Date of Patent: May 18, 2004Inventors: Edward Kolos, Jeffrey D. Newsom
-
Patent number: 6737068Abstract: The present invention relates to a liquid formulation for a feminine wipe. The preferred formulation has an anti-irritant agent, a pH adjuster namely citric acid, and at least one preservative.Type: GrantFiled: October 1, 2001Date of Patent: May 18, 2004Assignee: Playtex Products, Inc.Inventor: Catherine Durden
-
Patent number: 6733751Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: GrantFiled: March 10, 2003Date of Patent: May 11, 2004Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 6730329Abstract: One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic) at least one hydrocarbyl containing compound, and water. Another aspect of the invention relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions.Type: GrantFiled: February 26, 2002Date of Patent: May 4, 2004Inventor: Jeffrey B. Smith
-
Patent number: 6730288Abstract: A pharmaceutical aerosol foam composition including an effective amount of a pharmaceutically active ingredient; an occlusive agent; an aqueous solvent; and an organic cosolvent, the pharmaceutically active ingredient being insoluble in both water and the occlusive agent; the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use.Type: GrantFiled: January 30, 2001Date of Patent: May 4, 2004Assignee: Connetics Australia Pty LtdInventor: Albert Zorko Abram
-
Patent number: 6723349Abstract: The invention relates to a polyoxometalate topical composition for removing a contaminant from an environment, comprising a topical carrier and at least one polyoxometalate, with the proviso that the polyoxometalate is not H5PV2Mo10O40; K5Si(H2O)MnIIIW11O39; K4Si(H2O)MnIVW11O39; or K5CoIIIW12O40. The invention further relates to a method for removing a contaminant from an environment, comprising contacting the polyoxometalate topical composition of the present invention with the environment containing the contaminant for a sufficient time to remove the contaminant from the environment. The invention further relates to a modified polyoxometalate, wherein the modified polyoxometalate comprises the admixture of (1) a polyoxometalate and (2) a cerium compound, a silver compound, a gold compound, a platinum compound, or a combination thereof.Type: GrantFiled: October 11, 2000Date of Patent: April 20, 2004Assignee: Emory UniversityInventors: Craig L. Hill, Ling Xu, Jeffrey T. Rhule, Eric A. Boring
-
Patent number: 6709664Abstract: The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline.Type: GrantFiled: August 8, 2002Date of Patent: March 23, 2004Assignee: Somerset Pharmaceuticals, Inc.Inventor: Mark G. Resnick
-
Patent number: 6709663Abstract: A topical delivery composition which employs a multivesicular emulsion in combination with a pharmaceutically/pharmacologically active agent is disclosed. The multivesicular emulsion is formed from a quaternary amine salt emulsifier such as behentrimonium methosulfate. The emulsion is multi-lamellar which is a series of concentric spheres or vesiculars of oil and water phase that can be seen microscopically. As a result, the active is time released over a sustained period rather than spike released as is common with most topicals.Type: GrantFiled: August 31, 2001Date of Patent: March 23, 2004Assignee: HealthPoint, Ltd.Inventor: Robert Espinoza
-
Patent number: 6709681Abstract: The present invention provides a dosage form for the treatment of bacterial, viral or fungal conditions which comprises, a pharmaceutically acceptable acidifying agent in an amount sufficient to reduce the pH at an environment of use to below pH4, and a pharmaceutically acceptable source of nitrite ions or a nitrate precursor therefor; wherein said acidifying agent and said source of nitrite ions or nitrate precursor are separately disposed in respective pharmaceutically acceptable carriers for admixture at the intended environment of use to release NO or NO2 ions. The invention also provides delivery systems for the topical medicament.Type: GrantFiled: June 11, 1999Date of Patent: March 23, 2004Assignee: Aberdeen UniversityInventors: Nigel Benjamin, Hamish Dougall, Anthony Ormerod
-
Patent number: 6706696Abstract: The invention relates to cosmetic and/or pharmaceutical preparations containing (a) water soluble &bgr;-(1,3) glucans that are substantially devoid of &bgr;-(1,6) links, and (b) deoxyribonucleic acids and their breakdown and degradation products.Type: GrantFiled: February 1, 2002Date of Patent: March 16, 2004Assignee: Biotec ASAInventors: Ute Griesbach, Rolf Wachter, Achim Ansmann, Bernd Fabry, Rolf E. Engstad, Thomas Otto Gassenmeier
-
Patent number: 6699510Abstract: The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The indicator aspect provides ease of visually detecting the material on the animal skin and can indicate efficacy of the material. The compositions of the invention are made by combining an aqueous liquid composition containing the visual indicator combined with the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite.Type: GrantFiled: August 19, 2002Date of Patent: March 2, 2004Assignee: Ecolab Inc.Inventors: David D. McSherry, Francis L. Richter
-
Patent number: 6692775Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: June 24, 2002Date of Patent: February 17, 2004Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6692773Abstract: The invention relates to the use of one or more noble metals selected from silver, gold, platinum, and palladium but most preferably silver, in a nanocrystalline form, for the treatment of a hyperproliferative skin disorder or disease such as psoriasis. Among the noble metals, silver is preferred for such treatment. The nanocrystalline noble metal of choice may be used in the form of a nanocrystalline coating of one or more noble metals, a nanocrystalline powder of one or more noble metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more noble metals.Type: GrantFiled: July 27, 2001Date of Patent: February 17, 2004Assignee: Nucryst Pharmaceuticals Corp.Inventors: Robert Edward Burrell, John Barrymore Wright, Kan Lam
-
Patent number: 6689339Abstract: A carbon dioxide-containing viscous composition wherein carbon dioxide bubbles are retained in an aqueous viscous composition. Use of the composition makes it possible to treat or ameliorate itching accompanying mucocutaneous diseases or mucocutaneous disorders, mucocutaneous injury, dental diseases, skin ulcer, cryesthesia and numbness caused by peripheral circulatory disorders, musculoskeletal diseases, nervous system diseases, keratosis, constipation, unwanted hair re-growing after depilation, cosmetic troubles in the skin or hair, partial obesity, etc. while exerting little side effects.Type: GrantFiled: August 17, 2000Date of Patent: February 10, 2004Assignee: Medion Research Laboratories Inc.Inventors: Masaya Tanaka, Masato Hiki
-
Patent number: 6680062Abstract: The present invention relates to a cosmetic or pharmaceutical composition for topical application to the skin afflicted with rosacea and treated with a retinoid. The composition for treating rosacea comprises an anti-irritating component and several other components for treating rosacea. The other components form a mixture of a salicylic acid, a phytosphingosine, green tea, hinokitiol, gorgonian extract, and polysaccharide. The invention also provides a method for decreasing the irritation on the skin caused by the heightened sensitivity experienced by skin suffering from rosacea. The other components are effective in treating the rosacea condition, but particularly, in treating the telangiectasic symptom of rosacea.Type: GrantFiled: October 5, 2001Date of Patent: January 20, 2004Assignee: Color Access, Inc.Inventors: Neelam Muizzuddin, Kenneth D. Marenus, Daniel H. Maes
-
Patent number: 6676975Abstract: This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla chinensis, Caulis Clematis armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia rubra, Cortex Dictamni radicis, Herba Lopatheri, Spica Schizonepetae. The material comprises one or more of those components present in the freeze-dried decoction which run with Rf values in the ranges 0.00 to 0.100, 0.167 to 0.300, 0.400 to 0.533, 0.700 to 0.833 or 0.900 to 0.967 if the freeze-dried decoction is diluted in aqueous solution and subjected to chromatography on a Whatman 2 cms×55 cms×3 mm cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.Type: GrantFiled: February 14, 2002Date of Patent: January 13, 2004Assignee: Phytotech LimitedInventors: Brian Anthony Whittle, Jonathan Brostoff, Yvette Latchman
-
Patent number: 6653352Abstract: A composition containing capsicium extract together with other ingredients to neutralize the discomfort resulting from the application of capsicium extract to the skin enabling treatment of many types of discomforts, including arthritis pain, neuropathy, post surgical scarring, hemorrhoid pain and itching, and pruritis without the discomfort normally associated with the topical application of capsicium extract.Type: GrantFiled: March 6, 2001Date of Patent: November 25, 2003Assignee: Medical Merchandising, Inc.Inventors: Teresa Leigh Barr, Stephen D. Holt
-
Patent number: 6645482Abstract: Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.Type: GrantFiled: December 27, 2002Date of Patent: November 11, 2003Inventor: Theoharis C. Theoharides
-
Patent number: 6646011Abstract: The present invention relates to insect repellant compositions containing, based upon the total weight of the composition, from about 6 to about 30 percent by weight of insect repellant active material having functionality selected from ester, amide, urethane or combinations thereof; from about 5 to about 30 percent by weight of alcohol, and from about 1 to about 10 percent by weight of nonionic surfactant. The compositions of the invention exhibit reduced rates of degradation of the active material in solution and are less drying and irritating to sensitive skin.Type: GrantFiled: June 3, 1998Date of Patent: November 11, 2003Assignee: Johnson & Johnson Consumer Companies, Inc.Inventors: Danilo L. Lambino, Kennie U. Dee, Susan M. Niemiec
-
Patent number: 6641806Abstract: Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.Type: GrantFiled: December 27, 2002Date of Patent: November 4, 2003Inventor: Theoharis C. Theoharides
-
Patent number: 6638981Abstract: Topical compositions and methods for treating pain. The invention provides oil-in-water emulsions comprising an antidepressant; an NMDA-receptor antagonists; a lipophilic component; water; and a surfactant. The compositions induce a local-anesthetic effect when topically administered to intact skin thereby treating or preventing pain, for example, neuropathic pain.Type: GrantFiled: August 17, 2001Date of Patent: October 28, 2003Assignee: EpiCept CorporationInventors: Robert O. Williams, Feng Zhang
-
Patent number: 6635625Abstract: Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.Type: GrantFiled: December 27, 2002Date of Patent: October 21, 2003Inventor: Theoharis C. Theoharides
-
Publication number: 20030190335Abstract: Use of a polyamino polymer to inhibit the light-induced peroxidation of lipids, particularly inhibition of the photo-peroxidation of lipids induced by nanopigments. The invention also relates to the use of a polyamino polymer to inhibit the light-induced peroxidation of proteins. This property of polyamino polymers finds applications in particular in the cosmetics, pharmaceutical, veterinary and agrifood fields.Type: ApplicationFiled: May 22, 1998Publication date: October 9, 2003Inventors: BOUDIAF BOUSSOUIRA, CHRISTIAN COLIN
-
Patent number: 6613361Abstract: The invention concerns ketoprofen microgranules with prolonged release each consisting of an active core containing ketoprofen coated with a polymeric film enabling prolonged release of the active principle and containing acrylic polymer coatings in a volume proportion substantially equal to 90/10.Type: GrantFiled: November 15, 2001Date of Patent: September 2, 2003Assignee: Laboratoires des Produits Ethiques EthypharmInventors: Christophe Lebon, Dominique Marechal, Pascal Suplie
-
Patent number: 6599914Abstract: Methods of inhibiting the generation of pro-inflammatory cytokines such as IL-4 and IL-13 in a human patient in need of such inhibiting are disclosed.Type: GrantFiled: April 24, 2001Date of Patent: July 29, 2003Assignee: Schering CorporationInventors: Robert P. Schleimer, John Schroeder, William Kreutner
-
Patent number: 6599513Abstract: The present invention provides novel emulsion formulations which comprise oil bodies. The invention also provides a method for preparing the emulsions and the use of the emulsions in products for topical application to the skin. The products are very mild to the skin and may be easily formulated into a wide variety of personal care and dermatological products.Type: GrantFiled: October 24, 2001Date of Patent: July 29, 2003Assignee: Sembiosys Genetics Inc.Inventors: Harm M. Deckers, Gijs Van Rooijen, Joseph Boothe, Janis Goll, Maurice M. Moloney
-
Patent number: 6599512Abstract: Stable, topically applicable water-in-oil emulsions, well suited for therapeutically treating irritated/sensitive skins and having high electrolyte content, comprise (a) at least 26 by weight of at least one water-soluble metal salt, (b) at least one hydrophobic gelling agent, (c) less than 5% by weight of at least one emulsifying agent, and, advantageously, at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc., and/or at least one keratolytic active agent, neuropeptide antagonist and/or inflammation-mediator antagonist.Type: GrantFiled: October 3, 1997Date of Patent: July 29, 2003Assignee: La Roche Posay-Laboratoire PharmaceutiqueInventor: Véronique Burnier
-
Patent number: 6596704Abstract: Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The composition may be in sprayable form or dispersed in an aqueous solution. Methods of making and using the compositions are also described.Type: GrantFiled: June 28, 2001Date of Patent: July 22, 2003Assignee: Bristol-Myers Squibb CompanyInventors: Andrew D. Court, David D. Kershaw
-
Patent number: 6596287Abstract: The present invention provides novel emulsion formulations which comprise oil bodies. The invention also provides a method for preparing the emulsions and the use of the emulsions in products for topical application to the skin. The products are very mild to the skin and may be easily formulated into a wide variety of personal care and dermatological products.Type: GrantFiled: October 24, 2001Date of Patent: July 22, 2003Assignee: SemiBioSys Genetics Inc.Inventors: Harm M. Deckers, Gijs van Rooijen, Joseph Boothe, Janis Goll, Maurice M. Moloney
-
Patent number: 6593370Abstract: A topical capsaicin preparation for the treatment of painful cutaneous disorders and neural dysfunction is disclosed. The preparation contains a nonionic, amphoteric or cationic surfactant in an amount effective to eliminate or substantially ameliorate burning pain caused by capsaicin.Type: GrantFiled: November 12, 1999Date of Patent: July 15, 2003Assignee: Maruishi Pharmaceutical Co., Ltd.Inventors: Takashi Tamura, Urao Kawakami, Yuichi Teratani, Masakazu Yoshimura, Masahiko Seto
-
Treatment of psoriasis, allergies and auto-immune disorders of the skin with cis-6-hexadecenoic acid
Patent number: 6589520Abstract: A method for the prophylaxes and treatment of psoriasis, allergies and auto-immune disorders of the skin, the treatment of sensitive skin, or a combination thereof, which comprises applying cis-6-hexadecenoic acid, or a salt or ester thereof.Type: GrantFiled: April 17, 2000Date of Patent: July 8, 2003Assignee: Beiersdorf AGInventors: Udo Hoppe, Jurgen Jacob -
Patent number: 6582710Abstract: The present invention provides novel emulsion formulations which comprise oil bodies. The invention also provides a method for preparing the emulsions and the use of the emulsions in products for topical application to the skin. The products are very mild to the skin and may be easily formulated into a wide variety of personal care and dermatological products.Type: GrantFiled: January 29, 2002Date of Patent: June 24, 2003Assignee: Sembiosys Genetics Inc.Inventors: Harm M. Deckers, Gijs van Rooijen, Joseph Boothe, Janis Goll, Maurice M. Moloney
-
Patent number: 6579543Abstract: A composition for topical application to an animal's skin for relief from a variety of symptoms caused by medical conditions or physical injuries. The composition includes at least one compound having analgesic activity, at least one compound having anti-inflammatory activity, at least one compound having antioxidant activity, at least one compound having anti-neuralgic activity, at least one compound having blood circulation promotion activity, and at least one compound having antidepressant activity. A method for relieving pain by topical application of the composition is also provided.Type: GrantFiled: May 21, 2002Date of Patent: June 17, 2003Inventor: Jackie H. McClung
-
Patent number: 6579512Abstract: A pharmaceutical topical spray composition of corticosteroid, an alcohol, a propelant, and isopropyl myristate. A method for treating an inflammatory skin condition using the administration to the skin of a mammal of the pharmaceutical composition. The pharmaceutical composition is effective in the treatment of inflammatory skin conditions without the need for zinc pyrithione, undecylenic acid, or a detergent.Type: GrantFiled: June 15, 2001Date of Patent: June 17, 2003Inventor: Charles E. Crutchfield, III
-
Patent number: 6572848Abstract: Agonists of chlorine/potassium channel receptor, for example taurine, gamma-aminobutyric acid (GABA), isoguvacin, isonipecotic acid, 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyrid-3(2H)-one, a benzodiazepine, steroids, and cromakalim, pinacidil, nicorandil and minoxidil, are well suited for treating sensitive human skin and are especially useful for treating/eliminating skin itching, pruritus, tautness, tingling and/or erythema.Type: GrantFiled: April 28, 2000Date of Patent: June 3, 2003Assignee: Societe L'Oreal S.A.Inventors: Lionel Breton, Olivier De Lacharriere, Isabelle Nonotte
-
Patent number: 6569839Abstract: A pharmaceutical composition comprising at least one local anesthetic, at least one anti-inflammatory agent and at least one antibiotic are disclosed. The local anesthetic has a peak effect no later than about 10 minutes after administration to a mammal, and the anesthetic and anti-inflammatory have a half-life of no greater than about 36 hours after administration. The pharmaceutical composition, thus, advantageously provides rapid relief of pain with a substantially low residual accumulation of active components so that the pharmaceutical composition can be repeatedly or continuously administered to a wound. Embodiments include preparing a medicinal solution including Lidocaine as the local anesthetic, Hydrocortisone sodium succinate as the anti-inflammatory agent, Chloramphenicol as the antibiotic agent and, optionally, Heparin as an anticoagulant.Type: GrantFiled: November 30, 1999Date of Patent: May 27, 2003Inventor: Douglas William McKay
-
Patent number: 6544502Abstract: A method for treating a skin condition by intimately combining a water soluble antibiotic with the keratin layer of the outermost layer of the cleansed epidermis. The antibiotic is dissolved in the alkaline fraction of an electrolyzed water. The solution is characterized by the absence of hydrolysis products, turbidity, and loss of potency of the antibiotic. The aqueous solution is applied to the treatment area where the water is absorbed by the keratin and the antibiotic is carried into intimate contact with the keratin after which the water is evaporated leaving the antibiotic dispersed across the treatment area.Type: GrantFiled: May 15, 2001Date of Patent: April 8, 2003Assignee: Wasatch Pharmaceutical Inc.Inventor: Gary V. Heesch